↓ Skip to main content

NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients

Overview of attention for article published in Frontiers in immunology, December 2020
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
twitter
74 X users
patent
1 patent
facebook
1 Facebook page

Readers on

mendeley
152 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
NF-κB Pathway as a Potential Target for Treatment of Critical Stage COVID-19 Patients
Published in
Frontiers in immunology, December 2020
DOI 10.3389/fimmu.2020.598444
Pubmed ID
Authors

Ralf Kircheis, Emanuel Haasbach, Daniel Lueftenegger, Willm T. Heyken, Matthias Ocker, Oliver Planz

X Demographics

X Demographics

The data shown below were collected from the profiles of 74 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 152 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 152 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 20 13%
Researcher 18 12%
Student > Doctoral Student 12 8%
Student > Master 11 7%
Student > Ph. D. Student 10 7%
Other 22 14%
Unknown 59 39%
Readers by discipline Count As %
Medicine and Dentistry 27 18%
Biochemistry, Genetics and Molecular Biology 25 16%
Immunology and Microbiology 9 6%
Pharmacology, Toxicology and Pharmaceutical Science 8 5%
Neuroscience 4 3%
Other 14 9%
Unknown 65 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 58. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 April 2024.
All research outputs
#747,055
of 25,830,005 outputs
Outputs from Frontiers in immunology
#652
of 32,460 outputs
Outputs of similar age
#20,501
of 530,432 outputs
Outputs of similar age from Frontiers in immunology
#24
of 697 outputs
Altmetric has tracked 25,830,005 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,460 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 530,432 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 697 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.